𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rab11a Differentially Modulates Epidermal Growth Factor-induced Proliferation and Motility in Immortal Breast Cells

✍ Scribed by Diane Palmieri; Amina Bouadis; Ruban Ronchetti; Maria J. Merino; Patricia S. Steeg

Publisher
Springer US
Year
2006
Tongue
English
Weight
286 KB
Volume
100
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Downregulation of the antiapoptotic MCL-
Downregulation of the antiapoptotic MCL-1 protein and apoptosis in MA-11 breast cancer cells induced by an anti-epidermal growth factor receptor–Pseudomonas exotoxin a immunotoxin
✍ Yvonne Andersson; Siri Juell; Øystein Fodstad 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 582 KB

## Abstract __Pseudomonas__ exotoxin (PE)–containing immunotoxins (ITs) act by arresting protein synthesis and promoting apoptosis, but the mechanisms of the induced apoptosis and the relationship to protein synthesis inhibition is not well elucidated. We studied these effects in MA‐11 human breast

Inhibitory effects of a luteinizing horm
Inhibitory effects of a luteinizing hormone-releasing hormone agonist on basal and epidermal growth factor-induced cell proliferation and metastasis-associated properties in human epidermoid carcinoma a431 cells
✍ Ying-tang Huang; Jiuan-jiuan Hwang; Lung-ta Lee; Charles Liebow; Ping-ping H. Le 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 556 KB

## Abstract The purpose of this study was to investigate the effects of a potent LHRH agonist, [D‐Trp^6^]LHRH on the basal and EGF‐induced cell proliferation and the metastasis‐associated properties in A431 human epidermoid carcinoma. [D‐Trp^6^]LHRH time‐dependently inhibited the basal and EGF‐stim

Inhibition of proliferation and inductio
Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (‘Iressa’) is independent of EGFR expression level
✍ Manuela Campiglio; Alberta Locatelli; Clelia Olgiati; Nicola Normanno; Giulia So 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

High expression of the epidermal growth factor receptor (EGFR) in breast carcinoma confers a growth advantage to the tumor cells. The EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') has clinical activity in a wide range of tumor types, although the mechanism(s) by which it exerts its ant